CDCA7 抗体 (AA 201-300)
Quick Overview for CDCA7 抗体 (AA 201-300) (ABIN6988998)
抗原
See all CDCA7 抗体适用
宿主
克隆类型
标记
应用范围
-
-
抗原表位
- AA 201-300
-
交叉反应
- 人, 小鼠, 大鼠
-
预测反应
- Cow,Sheep,Pig,Rabbit
-
纯化方法
- Purified by Protein A.
-
免疫原
- KLH conjugated synthetic peptide derived from human CDCA7
-
亚型
- IgG
-
-
-
-
应用备注
- IHC-P 1:200-400
-
限制
- 仅限研究用
-
-
-
状态
- Liquid
-
浓度
- 1 μg/μL
-
缓冲液
- 0.01M TBS( pH 7.4) with 1 % BSA, 0.02 % Proclin300 and 50 % Glycerol.
-
储存液
- ProClin
-
注意事项
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.
-
储存条件
- 4 °C,-20 °C
-
储存方法
- Shipped at 4°C. Store at -20°C for one year. Avoid repeated freeze/thaw cycles.
-
有效期
- 12 months
-
-
- CDCA7 (Cell Division Cycle Associated 7 (CDCA7))
-
别名
- CDCA7
-
背景
-
Synonyms: CDCA7, CDCA 7, CDCA-7, Cell division cycle associated 7, JPO1, CDCA7_HUMAN.
Background: Participates in MYC-mediated cell transformation, induces anchorage-independent growth and clonogenicity in lymphoblastoid cells. Insufficient to induce tumorigenicity when overexpressed but contributes to MYC-mediated tumorigenesis. May play a role as transcriptional regulator.
-
基因ID
- 83879
-
UniProt
- Q9BWT1
抗原
-